Kalbe Farma Tbk PT
SWB:LCLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Kalbe Farma Tbk PT (LCLA) under the Base Case is EUR per share.
Compared with the current market price of 0.03 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Kalbe Farma Tbk PT Does
PT Kalbe Farma Tbk is one of Indonesia’s largest healthcare companies. It makes and sells prescription medicines, over-the-counter drugs, vitamins, nutritional products, and some medical-related products. Its brands are bought by hospitals, clinics, pharmacies, distributors, and everyday consumers who use its medicines and health supplements at home.
- Headquarters
- Indonesia ID
- Employees
- 12 895
- IPO date
- Jul 30, 1991
Kalbe Farma has no economic moat
Kalbe Farma Tbk PT lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisBalance Sheet
Continue LCLA Research
Decided on Kalbe Farma? Get an email when LCLA reaches the price you’d buy at. Free with an account.
Other Kalbe Farma listings
What is the Intrinsic Value of one LCLA stock?
The intrinsic value for
Kalbe Farma Tbk PT (LCLA) under the Base Case is EUR.
Is LCLA stock undervalued or overvalued?
Compared with the current market price of 0.03 EUR, the stock appears .